The expression of CARMN from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) showed a significant downregulation in 16 out of 31 tumor type cohorts compared with corresponding normal tissues, especially for cervical squamous carcinoma (CESC) (Fig. S4). Here, CARMN is linked to cervical squamous cell carcinoma.